J1305 HCPCS code: Injection, evinacumab-dgnb, 5mg
J1305 is the HCPCS Level II code for injection, evinacumab-dgnb, 5mg. In 2024 Medicare paid an average of $142.64 per service for J1305 across 72,462 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 480 per day on outpatient hospital claims. Medicare volume rose 151% from 2023 to 2024 (28,903 to 72,462 services). In 2024, about 61 clinicians billed Medicare for J1305 for 40 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2021-10-01 |
| Last action effective | 2021-10-01 |
Who bills J1305 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 61 |
| Medicare beneficiaries | 40 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1305, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 28,903 | 15 | $168.94 | $134.59 |
| 2024 | 72,462 | 40 | $179.04 | $142.64 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 480 | CMS Policy |
| practitioner claims | 480 | CMS Policy |
What changed for J1305
- 2021-10-01: J1305 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1305?
J1305 is the HCPCS Level II code for injection, evinacumab-dgnb, 5mg. Short descriptor: "Inj, evinacumab-dgnb, 5mg".
How much does Medicare pay for J1305?
In 2024, the average Medicare payment was $142.64 per service (average allowed $179.04).
Does Medicare cover J1305?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1305 can be billed per day?
480 on outpatient hospital claims; 480 on practitioner claims (NCCI medically unlikely edits).
Related J13 codes
- J1300 — Injection, eculizumab, 10 mg
- J1301 — Injection, edaravone, 1 mg
- J1302 — Injection, sutimlimab-jome, 10 mg
- J1303 — Injection, ravulizumab-cwvz, 10 mg
- J1304 — Injection, tofersen, 1 mg
- J1306 — Injection, inclisiran, 1 mg
- J1307 — Injection, crovalimab-akkz, 10 mg
- J1308 — Injection, famotidine, 0.25 mg
- J1320 — Injection, amitriptyline hcl, up to 20 mg
- J1322 — Injection, elosulfase alfa, 1 mg
- J1323 — Injection, elranatamab-bcmm, 1 mg
- J1324 — Injection, enfuvirtide, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1305
- Watch J1305 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1305
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.